Skip to content

Clinical trials

Demyelinating Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Demyelinating Diseases Country / region: United States Clear all

53 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20032
20041
20061
20072
20081
20092
20101
20111
20141
20155
20161
20173
20183
20193
20203
20216
20222
20233
20241
20251
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27
Terminated8
Recruiting4
Unknown status4
Withdrawn3
Suspended2
Not yet recruiting2
Active, not recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Neurological Disorders and Stroke (NINDS)6
Acorda Therapeutics4
Alexion Pharmaceuticals, Inc.4
Healeon Medical Inc2
Holy Name Medical Center, Inc.2
Massachusetts General Hospital2
SwanBio Therapeutics, Inc.2
University of California, San Francisco2
University of Texas at Austin2
University of Washington2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Demyelinating Diseases53
Multiple Sclerosis32
Autoimmune Diseases13
Nervous System Diseases12
Autoimmune Diseases of the Nervous System9
Demyelinating Autoimmune Diseases, CNS8
Immune System Diseases8
Multiple Sclerosis, Relapsing-Remitting6
Neuromyelitis Optica6
Optic Neuritis6

Trials

Showing 1 to 25 of 53. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.